| Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient A Jiménez-Sánchez, D Memon, S Pourpe, H Veeraraghavan, Y Li, ... Cell 170 (5), 927-938. e20, 2017 | 472 | 2017 |
| UVB-induced tumor heterogeneity diminishes immune response in melanoma Y Wolf, O Bartok, S Patkar, GB Eli, S Cohen, K Litchfield, R Levy, ... Cell 179 (1), 219-235. e21, 2019 | 357 | 2019 |
| Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy A Jiménez-Sánchez, P Cybulska, KLV Mager, S Koplev, O Cast, ... Nature Genetics 52 (6), 582-593, 2020 | 187 | 2020 |
| Comprehensive benchmarking and integration of tumor microenvironment cell estimation methods A Jiménez-Sánchez, O Cast, ML Miller Cancer Research 79 (24), 6238-6246, 2019 | 149 | 2019 |
| Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8 T Walle, JA Kraske, B Liao, B Lenoir, C Timke, E von Bohlen und Halbach, ... Science advances 8 (12), eabh4050, 2022 | 91 | 2022 |
| Lack of detectable neoantigen depletion signals in the untreated cancer genome J Van den Eynden, A Jiménez-Sánchez, ML Miller, E Larsson Nature genetics 51 (12), 1741-1748, 2019 | 69 | 2019 |
| Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease–Associated Colorectal Cancers S Din, K Wong, MF Mueller, A Oniscu, J Hewinson, CJ Black, ML Miller, ... Clinical Cancer Research 24 (20), 5133-5142, 2018 | 40 | 2018 |
| Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases R Rabbie, N Ansari-Pour, O Cast, D Lau, F Scott, SJ Welsh, C Parkinson, ... Nature communications 11 (1), 4306, 2020 | 32 | 2020 |
| Integrated multi-tumor radio-genomic marker of outcomes in patients with high serous ovarian carcinoma H Veeraraghavan, HA Vargas, A Jimenez-Sanchez, M Micco, E Mema, ... Cancers 12 (11), 3403, 2020 | 30 | 2020 |
| Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2 C Aguilar, C Aguilar, R Lopez-Marure, A Jiménez-Sánchez, ... Molecular medicine reports 9 (5), 1895-1902, 2014 | 26 | 2014 |
| Coevolution of RAC small GTPases and their regulators GEF proteins A Jiménez-Sánchez Evolutionary Bioinformatics 12, EBO. S38031, 2016 | 7 | 2016 |
| Lack of detectable neoantigen depletion in the untreated cancer genome JV Eynden, A Jiménez-Sánchez, ML Miller, E Larsson BioRxiv, 478263, 2018 | 5 | 2018 |
| Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations N Bharti, L Santos, M Davyt, S Behrmann, M Eichholtz, ... Nature Communications 15 (1), 2957, 2024 | 4 | 2024 |
| Multi-site clonality analyses uncovers pervasive subclonal heterogeneity and branching evolution across melanoma metastases R Rabbie, N Ansari-Pour, O Cast, D Lau, F Scott, SJ Welsh, C Parkinson, ... BioRxiv, 848390, 2019 | 3 | 2019 |
| Characterisation of the tumour microenvironment in ovarian cancer A Jiménez Sánchez | 2 | 2019 |
| Tumor progression and tumor microenvironment of pancreas cancer ascites revealed by scRNA-seq and spatial transcriptomics S Umeda, ER Karnoub, F Balogun, A Jiménez-Sánchez, ... Cancer Research 84 (6_Supplement), 1273-1273, 2024 | | 2024 |
| Optimal tumor metastatic gene programs in pancreatic cancer A Jiménez-Sánchez, Y Xie, R Sharma, TY Chu, V Liu, W Park, A Hayashi, ... Cancer Research 82 (12_Supplement), 279-279, 2022 | | 2022 |
| La región 3¿ UTR del genoma de WNV es una excelente diana para el desarrollo de fármacos antivirales. SE Ramos-Lorente, B Berzal-Herranz, A Jiménez-Sánchez, ... | | 2022 |
| The 3’UTR of WNV genome is an excellent target for antiviral drugs SE Ramos-Lorente, B Berzal-Herranz, A Jiménez-Sánchez, ... MDPI, 2021 | | 2021 |
| Implicaciones funcionales de dominios conservados de genomas RNA A Berzal-Herranz, A Jiménez Sánchez | | 2021 |
Martin L MillerSenior Director, AstraZenecaVerified email at astrazeneca.com
